Pacific women are calling for better cancer education and more culturally responsive healthcare, with new research finding ...
Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets innovative interventional MRI (iMRI) procedures, will ...
The FDA just approved a new drug for use in ER+/HER2- metastatic breast cancer, based on a large study led by Fred Hutch's Dr. Sara Hurvitz. The new drug, gedatolisib, is a multi-targeted kinase ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results